2 Biotech Penny Stocks That Are Vastly Superior Investments to Dogecoin
Dogecoin (CRYPTO: DOGE), in many ways, is at the epicenter of the cryptocurrency craze. Its price appreciated by a staggering 12,000% during just the first five months of 2021. The probability that this star of the cryptocurrency world will keep churning higher, however, appears to be slim at this point. In fact, Dogecoin's price has fallen by more than 58% from its recent highs, implying that the rampant enthusiasm that drove the coin's price through the roof earlier this year may be waning, perhaps for good.
So, with the crypto bubble on shaky ground, aggressive investors might be wise to consider alternative growth vehicles soon. The good news is that there are a handful of biotech penny stocks (equities with a sub-$5 share price) capable of delivering jaw-dropping returns for risk-tolerant investors. Adaptimmune Therapeutics (NASDAQ: ADAP) and Verastem (NASDAQ: VSTM), for instance, both have the ingredients necessary to go on a sustained growth spurt. Here's a rundown of the core value propositions associated with these two small-cap biotech companies.
Image source: Getty Images.
Source Fool.com
